Meduloc, Inc. — SEC Form D Filing

Meduloc, Inc. filed an SEC Form D on August 6, 2026, reporting $1.84M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 6, 2026
Amount reported
$1.84M
Round stage
Seed
Industry
Medical Devices
Website
https://www.meduloc.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

There is a need for improved fixation of small, long-bone fractures, implying current methods may not provide stable fixation or secure reduction.

Solution

Meduloc is developing minimally invasive, intramedullary implants designed to provide stable fixation and secure reduction for various small, long-bone fractures.

Why now

The demand for improved fixation methods in orthopedic surgery, particularly for small long bones, is an ongoing clinical need that Meduloc aims to address with innovative internal fixation solutions.

Verdict

This cleared because it promised a surgical efficacy upgrade in a specific, high-volume procedure, not because it disrupted a broad market. Investors were implicitly betting on a faster, more stable fixation method translating directly to better patient outcomes and surgeon preference, despite the sales cycle challenges of medical devices. The upside was limited by the relatively narrow application of small long-bone fractures, suggesting a potential feature, not a platform, unless further expansion was viable.

Source: SEC EDGAR Form D filing